-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Catalyst Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2018 to 2023.
- Catalyst Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 125M shares, a 17.7% increase year-over-year.
- Catalyst Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 114M shares, a 2.14% increase from 2022.
- Catalyst Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 111M shares, a 3.32% increase from 2021.
- Catalyst Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 108M shares, a 1.46% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)